especially in the developing and least developed countries, where it is difficult to maintain both the
controlled environment for manufacturing and quality control. Moreover, lack of proper refrigeration or
environment controllable transportation facilities hinder the uniform quality of biological drugs in different
regions, due to contamination at different stages. However, the need for effective medicines for illnesses like
cancer, autoimmune diseases, and other chronic illnesses with minimal side effects when compared to
chemical drugs is expected to provide opportunities for major players in the biological drugs market during
the forecast period.
Get Sample Copy of this Report:-
https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/15
Segments Covered:
The report segments the global biological drugs market by product and region. On the basis of product, the
market is segmented as protein therapy, mAb therapy and vaccines. Monoclonal antibodies segment is
expected to sustain a major share in the global biological drugs market during the forecast period. Among
protein therapy segment, Enbrel is expected to attain more demand with fastest growth rate during the
forecast period. Among the vaccines, the demand for Prevnar 13 is anticipated to grow significantly during
the forecast period.
Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and
Rest of the World. North America dominates the global biological drugs market with a major share. Increasing
technological advancements, favorable regulatory policies and increasing awareness about the biological due
to intervention of governments and other agencies are the major factors that drive the growth of the North
American biological drugs market. Moreover, the increasing demand for biological drugs for the treatment of
chronic illnesses such as cancer and diabetes is anticipated to drive the growth of the North American
biological market during the forecast period.
Infinium Global Research